Jadbio – Biomarker Discovery Accelerator with AutoML is a pioneering machine learning solution that revolutionizes the process of biomarker discovery, all without the need for coding. This powerful tool harnesses the capabilities of automated machine learning to decipher the intricate role of biomarkers tailored to specific research objectives.

Accessible through the AWS Marketplace, Jadbio empowers researchers to expedite drug discovery while optimizing costs by seamlessly integrating technology into the discovery workflow.

The platform boasts the ability to analyze a diverse array of multi-omics data types, encompassing genomics, transcriptomics, metagenomics, proteomics, metabolomics, clinical data, and even images. This versatility equips researchers with the agility to swiftly and effectively glean critical insights essential for their investigative work.

Jadbio’s impact spans diverse domains, from early biomarker discovery to drug repurposing and unraveling treatment response mechanisms, among others. The tool further distinguishes itself with its no-code machine learning functionality, enabling users to effortlessly automate biomarker discovery aligned with their specific research requisites.

To facilitate researchers in harnessing the full potential of the platform, Jadbio offers a wealth of supporting resources, including illuminating case studies, informative webinars, and a comprehensive glossary.

Additionally, Jadbio has cultivated strategic partnerships with esteemed organizations such as Indivumed, QIAGEN, Ledidi, BioLizard, and Elucidata, bolstering its commitment to advancing research endeavors.

For researchers eager to embark on their biomarker discovery journey, Jadbio extends the opportunity to sign up for a free Jadbio AutoML account, opening the door to a world of innovative possibilities.